PGNY
Progyny, Inc.
Price Chart
Latest Quote
$26.62
+0.54 (+2.07%)
Current Price
| Previous Close | $26.08 |
| Open | $26.43 |
| Day High | $26.93 |
| Day Low | $26.38 |
| Volume | 471,999 |
Stock Information
| Shares Outstanding | 78.33M |
| Total Debt | $27.28M |
| Cash Equivalents | $225.11M |
| Revenue | $1.29B |
| Net Income | $67.69M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $2.09B |
| P/E Ratio | 34.57 |
| EPS (TTM) | $0.77 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.85B |
| Sales | $1.29B |
| Income | $67.69M |
| Book/sh | $5.66 |
| Cash/sh | $2.87 |
| Employees | 835 |
Financial Ratios
| Quick Ratio | 2.07 |
| Current Ratio | 2.13 |
| Debt/Eq | 6.21 |
| EPS Growth TTM | 60.90% |
Returns & Margins
| ROA | 9.12% |
| ROE | 14.94% |
| Gross Margin | 24.11% |
| Operating Margin | 10.77% |
| Profit Margin | 5.24% |
Ownership
| Insider Ownership | 1.94% |
| Institutional Ownership | 112.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 12.06 |
| P/S | 1.61 |
| P/B | 4.70 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $29.73 |
Technical Indicators
| SMA20 | $25.84 |
| SMA50 | $22.35 |
| SMA200 | $22.10 |
| RSI | 54.07 |
| ATR | 0.8450 |
| Shares Float | 71.61M |
| Short Float | 9.09% |
| Short Ratio | 2.88 |
| Volatility | 1.04 |
| Rel Volume | 0.32 |
Performance History
| Week | -0.04% |
| Month | +3.82% |
| Quarter | +46.83% |
| 6 Months | +2.42% |
| YTD | +3.42% |
| Year | +22.96% |
| 3 Years | -32.44% |
| 5 Years | -58.71% |
| 10 Years | +67.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $26.62 | 471,999 |
| 2026-06-18 | $26.08 | 3,065,100 |
| 2026-06-17 | $26.31 | 1,178,700 |
| 2026-06-16 | $26.60 | 1,757,500 |
| 2026-06-15 | $26.91 | 1,373,100 |
| 2026-06-12 | $26.63 | 1,313,500 |
| 2026-06-11 | $25.65 | 1,200,800 |
| 2026-06-10 | $25.89 | 1,122,300 |
| 2026-06-09 | $25.83 | 1,588,400 |
| 2026-06-08 | $25.92 | 1,612,900 |
| 2026-06-05 | $25.86 | 1,229,200 |
| 2026-06-04 | $25.48 | 953,900 |
| 2026-06-03 | $24.99 | 1,403,100 |
| 2026-06-02 | $25.12 | 2,142,700 |
| 2026-06-01 | $26.20 | 1,822,900 |
| 2026-05-29 | $25.56 | 1,307,700 |
| 2026-05-28 | $25.69 | 1,222,600 |
| 2026-05-27 | $25.48 | 2,256,700 |
| 2026-05-26 | $25.05 | 1,107,700 |
| 2026-05-22 | $24.88 | 1,464,400 |
About Progyny, Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
đ° Latest News
1 Russell 2000 Stock for Long-Term Investors and 2 We Turn Down
StockStory âĸ 2026-06-19T14:36:58Z
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders
Simply Wall St. âĸ 2026-06-10T14:08:06Z
Progyny (PGNY) Authorizes $200M Share Repurchase Program
Insider Monkey âĸ 2026-06-04T16:51:09Z
Conservative Guidance Weighed on Progyny (PGNY) Amid Strong Demand and Solid Execution
Insider Monkey âĸ 2026-06-04T14:21:28Z
3 Cash-Heavy Stocks That Concern Us
StockStory âĸ 2026-06-02T11:01:23Z
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000
Motley Fool âĸ 2026-05-31T15:22:49Z
Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook
Simply Wall St. âĸ 2026-05-24T10:07:06Z
3 Stocks Under $50 with Warning Signs
StockStory âĸ 2026-05-21T20:44:55Z
Progyny (PGNY) Stock Is Up, What You Need To Know
StockStory âĸ 2026-05-21T13:32:55Z
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-05-19T13:34:39Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $984,177,000 | $913,858,000 | $849,799,000 | $619,588,000 |
| Cost Of Revenue | $984,177,000 | $913,858,000 | $849,799,000 | $619,588,000 |
| Total Revenue | $1,288,661,000 | $1,167,221,000 | $1,088,598,000 | $786,913,000 |
| Operating Revenue | $1,288,661,000 | $1,167,221,000 | $1,088,598,000 | $786,913,000 |
| Expenses | ||||
| Total Expenses | $1,203,384,000 | $1,099,766,000 | $1,026,414,000 | $763,572,000 |
| Net Non Operating Interest Income Expense | $10,155,000 | $15,747,000 | $8,507,000 | $1,100,000 |
| Operating Expense | $219,207,000 | $185,908,000 | $176,615,000 | $143,984,000 |
| Selling And Marketing Expense | $72,113,000 | $63,948,000 | $59,488,000 | $45,657,000 |
| General And Administrative Expense | $147,094,000 | $121,960,000 | $117,127,000 | $98,327,000 |
| Other Income Expense | - | - | $5,203,000 | $286,000 |
| Other Non Operating Income Expenses | - | - | $5,203,000 | $286,000 |
| Total Other Finance Cost | - | - | $-3,304,000 | $-814,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Net Interest Income | $10,155,000 | $15,747,000 | $8,507,000 | $1,100,000 |
| Interest Income | $10,155,000 | $15,747,000 | $8,507,000 | $1,100,000 |
| Normalized Income | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Net Income From Continuing And Discontinued Operation | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Total Operating Income As Reported | $85,277,000 | $67,455,000 | $62,184,000 | $23,341,000 |
| Net Income Common Stockholders | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Net Income | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Net Income Including Noncontrolling Interests | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Net Income Continuous Operations | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Pretax Income | $95,432,000 | $83,202,000 | $70,691,000 | $24,441,000 |
| Interest Income Non Operating | $10,155,000 | $15,747,000 | $8,507,000 | $1,100,000 |
| Operating Income | $85,277,000 | $67,455,000 | $62,184,000 | $23,341,000 |
| Gross Profit | $304,484,000 | $253,363,000 | $238,799,000 | $167,325,000 |
| Per Share | ||||
| Diluted EPS | $0.65 | $0.57 | $0.62 | $0.30 |
| Basic EPS | $0.68 | $0.59 | $0.65 | $0.33 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $90,225,000 | $70,630,000 | $64,465,000 | $24,942,000 |
| Reconciled Depreciation | $4,948,000 | $3,175,000 | $2,281,000 | $1,601,000 |
| EBITDA (Bullshit earnings) | $90,225,000 | $70,630,000 | $64,465,000 | $24,942,000 |
| EBIT | $85,277,000 | $67,455,000 | $62,184,000 | $23,341,000 |
| Diluted Average Shares | $89,861,843 | $95,448,357 | $100,672,399 | $99,957,173 |
| Basic Average Shares | $85,651,721 | $91,481,995 | $95,021,175 | $92,195,068 |
| Diluted NI Availto Com Stockholders | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Tax Provision | $36,912,000 | $28,866,000 | $8,654,000 | $-5,917,000 |
| Selling General And Administration | $219,207,000 | $185,908,000 | $176,615,000 | $143,984,000 |
| Other Gand A | $147,094,000 | $121,960,000 | $117,127,000 | $98,327,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $489,850,000 | $405,225,000 | $541,549,000 | $364,989,000 |
| Total Assets | $742,435,000 | $607,102,000 | $756,620,000 | $542,986,000 |
| Total Non Current Assets | $190,660,000 | $134,381,000 | $116,213,000 | $109,130,000 |
| Other Non Current Assets | $16,536,000 | $2,977,000 | $3,395,000 | $3,988,000 |
| Non Current Deferred Assets | $93,013,000 | $84,933,000 | $73,120,000 | $77,889,000 |
| Non Current Deferred Taxes Assets | $93,013,000 | $84,933,000 | $73,120,000 | $77,889,000 |
| Goodwill And Other Intangible Assets | $26,194,000 | $16,837,000 | $11,880,000 | $11,979,000 |
| Other Intangible Assets | $6,216,000 | $1,303,000 | - | $99,000 |
| Current Assets | $551,775,000 | $472,721,000 | $640,407,000 | $433,856,000 |
| Other Current Assets | $21,392,000 | $9,443,000 | $27,451,000 | $4,489,000 |
| Receivables | $220,287,000 | $235,324,000 | $241,869,000 | $240,067,000 |
| Accounts Receivable | $220,287,000 | $235,324,000 | $241,869,000 | $240,067,000 |
| Allowance For Doubtful Accounts Receivable | $-55,659,000 | $-56,355,000 | $-46,636,000 | $-28,328,000 |
| Gross Accounts Receivable | $275,946,000 | $291,679,000 | $288,505,000 | $268,395,000 |
| Cash Cash Equivalents And Short Term Investments | $310,096,000 | $227,954,000 | $371,087,000 | $189,300,000 |
| Cash And Cash Equivalents | $112,238,000 | $162,314,000 | $97,296,000 | $120,078,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $27,726,000 | $19,272,000 | $19,390,000 | $7,713,000 |
| Long Term Debt And Capital Lease Obligation | $24,000,000 | $16,413,000 | $17,241,000 | $6,482,000 |
| Current Debt And Capital Lease Obligation | $3,726,000 | $2,859,000 | $2,149,000 | $1,231,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $226,391,000 | $185,040,000 | $203,191,000 | $166,018,000 |
| Total Non Current Liabilities Net Minority Interest | $24,000,000 | $16,413,000 | $17,241,000 | $6,482,000 |
| Current Liabilities | $202,391,000 | $168,627,000 | $185,950,000 | $159,536,000 |
| Other Current Liabilities | $1,914,000 | $5,299,000 | $1,183,000 | $1,169,000 |
| Payables And Accrued Expenses | $175,186,000 | $145,897,000 | $170,750,000 | $149,430,000 |
| Payables | $154,025,000 | $127,218,000 | $155,720,000 | $140,426,000 |
| Other Payable | $29,954,000 | $32,121,000 | $30,294,000 | $31,139,000 |
| Accounts Payable | $124,071,000 | $95,097,000 | $125,426,000 | $109,287,000 |
| Equity | ||||
| Common Stock Equity | $516,044,000 | $422,062,000 | $553,429,000 | $376,968,000 |
| Total Equity Gross Minority Interest | $516,044,000 | $422,062,000 | $553,429,000 | $376,968,000 |
| Stockholders Equity | $516,044,000 | $422,062,000 | $553,429,000 | $376,968,000 |
| Gains Losses Not Affecting Retained Earnings | $498,000 | $39,000 | $2,819,000 | $501,000 |
| Other Equity Adjustments | $498,000 | $39,000 | $2,819,000 | $501,000 |
| Retained Earnings | $202,827,000 | $144,307,000 | $89,971,000 | $27,934,000 |
| Other | ||||
| Treasury Shares Number | $16,299,769 | $12,998,173 | $615,980 | $615,980 |
| Ordinary Shares Number | $83,365,696 | $85,310,698 | $96,348,522 | $93,301,156 |
| Share Issued | $99,665,465 | $98,308,871 | $96,964,502 | $93,917,136 |
| Tangible Book Value | $489,850,000 | $405,225,000 | $541,549,000 | $364,989,000 |
| Invested Capital | $516,044,000 | $422,062,000 | $553,429,000 | $376,968,000 |
| Working Capital | $349,384,000 | $304,094,000 | $454,457,000 | $274,320,000 |
| Capital Lease Obligations | $27,726,000 | $19,272,000 | $19,390,000 | $7,713,000 |
| Total Capitalization | $516,044,000 | $422,062,000 | $553,429,000 | $376,968,000 |
| Treasury Stock | $388,075,000 | $303,889,000 | $1,009,000 | $1,009,000 |
| Additional Paid In Capital | $700,785,000 | $581,596,000 | $461,639,000 | $349,533,000 |
| Capital Stock | $9,000 | $9,000 | $9,000 | $9,000 |
| Common Stock | $9,000 | $9,000 | $9,000 | $9,000 |
| Long Term Capital Lease Obligation | $24,000,000 | $16,413,000 | $17,241,000 | $6,482,000 |
| Current Capital Lease Obligation | $3,726,000 | $2,859,000 | $2,149,000 | $1,231,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $21,565,000 | $14,572,000 | $11,868,000 | $7,706,000 |
| Current Accrued Expenses | $21,161,000 | $18,679,000 | $15,030,000 | $9,004,000 |
| Goodwill | $19,978,000 | $15,534,000 | $11,880,000 | $11,880,000 |
| Net PPE | $54,917,000 | $29,634,000 | $27,818,000 | $15,274,000 |
| Accumulated Depreciation | $-12,344,000 | $-8,368,000 | $-5,301,000 | $-3,119,000 |
| Gross PPE | $67,261,000 | $38,002,000 | $33,119,000 | $18,393,000 |
| Leases | $4,850,000 | $4,397,000 | $3,733,000 | $3,394,000 |
| Other Properties | $24,990,000 | $17,251,000 | $17,605,000 | $6,903,000 |
| Machinery Furniture Equipment | $37,421,000 | $16,354,000 | $11,781,000 | $8,096,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $197,858,000 | $65,640,000 | $273,791,000 | $69,222,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $191,782,000 | $173,700,000 | $185,170,000 | $77,154,000 |
| Operating Activities | ||||
| Operating Cash Flow | $210,192,000 | $179,105,000 | $188,814,000 | $80,395,000 |
| Cash Flow From Continuing Operating Activities | $210,192,000 | $179,105,000 | $188,814,000 | $80,395,000 |
| Operating Gains Losses | $79,000 | $1,414,000 | $-8,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-18,410,000 | $-5,405,000 | $-3,644,000 | $-3,241,000 |
| Investing Cash Flow | $-159,013,000 | $195,792,000 | $-200,525,000 | $-43,866,000 |
| Cash Flow From Continuing Investing Activities | $-159,013,000 | $195,792,000 | $-200,525,000 | $-43,866,000 |
| Cash From Discontinued Investing Activities | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-81,657,000 | $-300,278,000 | $0 | $0 |
| Financing Cash Flow | $-99,362,000 | $-309,880,000 | $-11,072,000 | $-7,864,000 |
| Cash Flow From Continuing Financing Activities | $-99,362,000 | $-309,880,000 | $-11,072,000 | $-7,864,000 |
| Net Other Financing Charges | $-18,935,000 | $-12,001,000 | $-17,200,000 | $-12,089,000 |
| Net Common Stock Issuance | $-81,657,000 | $-300,278,000 | $0 | $0 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $55,490,000 | $40,449,000 | $6,181,000 | $133,000 |
| End Cash Position | $114,193,000 | $162,314,000 | $97,296,000 | $120,078,000 |
| Beginning Cash Position | $162,314,000 | $97,296,000 | $120,078,000 | $91,413,000 |
| Effect Of Exchange Rate Changes | $62,000 | $1,000 | $1,000 | $0 |
| Changes In Cash | $-48,183,000 | $65,017,000 | $-22,783,000 | $28,665,000 |
| Proceeds From Stock Option Exercised | $1,230,000 | $2,399,000 | $6,128,000 | $4,225,000 |
| Common Stock Payments | $-81,657,000 | $-300,278,000 | $0 | $0 |
| Net Investment Purchase And Sale | $-131,263,000 | $206,501,000 | $-196,881,000 | $-40,625,000 |
| Sale Of Investment | $223,701,000 | $376,840,000 | $232,813,000 | $122,709,000 |
| Purchase Of Investment | $-354,964,000 | $-170,339,000 | $-429,694,000 | $-163,334,000 |
| Net Business Purchase And Sale | $-9,340,000 | $-5,304,000 | $0 | $0 |
| Purchase Of Business | $-9,340,000 | $-5,304,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-18,410,000 | $-5,405,000 | $-3,644,000 | $-3,241,000 |
| Purchase Of PPE | $-18,410,000 | $-5,405,000 | $-3,644,000 | $-3,241,000 |
| Change In Working Capital | $2,799,000 | $-11,775,000 | $-17,424,000 | $-59,491,000 |
| Change In Other Working Capital | $-9,306,000 | $425,000 | $648,000 | $-1,080,000 |
| Change In Payables And Accrued Expense | $29,169,000 | $-20,344,000 | $26,596,000 | $60,836,000 |
| Change In Accrued Expense | $417,000 | $9,924,000 | $10,361,000 | $13,147,000 |
| Change In Payable | $28,752,000 | $-30,268,000 | $16,235,000 | $47,689,000 |
| Change In Account Payable | $28,752,000 | $-30,268,000 | $16,235,000 | $47,689,000 |
| Change In Prepaid Assets | $-11,947,000 | $18,018,000 | $-22,930,000 | $57,000 |
| Change In Receivables | $-5,117,000 | $-9,874,000 | $-21,738,000 | $-119,304,000 |
| Changes In Account Receivables | $-5,117,000 | $-9,874,000 | $-21,738,000 | $-119,304,000 |
| Other Non Cash Items | $434,000 | - | $-34,000 | - |
| Stock Based Compensation | $131,867,000 | $128,130,000 | $122,611,000 | $100,748,000 |
| Asset Impairment Charge | $20,526,000 | $16,396,000 | $19,934,000 | $13,794,000 |
| Amortization Of Securities | $-866,000 | $-2,115,000 | $-4,328,000 | - |
| Deferred Tax | $-8,115,000 | $-10,456,000 | $3,745,000 | $-6,615,000 |
| Deferred Income Tax | $-8,115,000 | $-10,456,000 | $3,745,000 | $-6,615,000 |
| Depreciation Amortization Depletion | $4,948,000 | $3,175,000 | $2,281,000 | $1,601,000 |
| Depreciation And Amortization | $4,948,000 | $3,175,000 | $2,281,000 | $1,601,000 |
| Net Foreign Currency Exchange Gain Loss | $0 | $0 | $-8,000 | $0 |
| Gain Loss On Sale Of PPE | $79,000 | $1,414,000 | $0 | $0 |
| Net Income From Continuing Operations | $58,520,000 | $54,336,000 | $62,037,000 | $30,358,000 |
| Gain Loss On Investment Securities | - | $-2,115,000 | $-4,328,000 | - |
| Repayment Of Debt | - | - | - | - |
| Issuance Of Debt | - | - | - | - |
| Interest Paid Supplemental Data | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-18